Increasing evidence from both in vitro and in vivo studies supports the concept that PPAR-γ deficiency produce an environment prone to tumorigenesis, while PPAR-γ overexpression may inhibit HCC growth. Here, PPARG is linked to hepatocellular carcinoma.